Observational studyMultiple sclerosis and related disorders2022

Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data.

Samantha Epstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.